L200 (Carbidopa and levodopa extended-release 50 mg / 200 mg)
This pill with imprint "L200" is Peach, Elliptical / Oval and has been identified as Carbidopa and levodopa extended-release 50 mg / 200 mg. It is manufactured by Accord Healthcare, Inc..
Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about carbidopa/levodopa
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 41 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
- Carbidopa and levodopa
- Carbidopa and levodopa extended-release capsules
- Carbidopa and levodopa orally disintegrating tablets
- Carbidopa and levodopa suspension
- Carbidopa and levodopa sustained-release tablets
- More... (6)
Related treatment guides
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.